According to the SEC complaint: "And, in a text m
Post# of 148112
Given Amarex charged CYDY an additional $150k to complete the BLA by the end of February, and given the massive amount of data that was still missing from the BLA when they submitted it at the end of February, it shows a significant level of incompetence and/or fraud on the part of Amarex. In my opinion, NP's desperate and fraudulent request to submit the BLA knowing it was incomplete doesn't justify Amarex's poor performance and excuse them from their contractual obligations to CytoDyn.